ÂÜÀòÂÒÂ×

Daniel Merz is an accomplished professional with extensive experience in the medical technology sector. Currently serving as Chief Technology Officer and EVP of Quality, Regulatory, and Clinical Affairs at LABORIE since April 2018, Daniel previously held significant roles at Cogentix Medical, Inc., including Vice President of R&D, Clinical, Regulatory, Quality, and Reimbursement. Prior positions include leadership at Uroplasty, Inc., St. Jude Medical, and American Medical Systems, where Daniel led clinical and regulatory departments and managed various clinical programs. Daniel's educational background includes a Bachelor of Science in Biomedical Engineering from Northwestern University, completed in 1999.